Genetically activating IGN via overexpression of intestinal glucose-6-phosphatase can counteract the pro-obesity and pro-diabetes effects of consuming high-calorie foods [32]. Here, G6PC1 is linked to obesity due to melanocortin 4 receptor deficiency.